These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38876182)

  • 1. Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy.
    Efros MD; Kaminetsky JC; Sherman ND; Chan A; Thomas JW
    Endocr Pract; 2024 Sep; 30(9):847-853. PubMed ID: 38876182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-arm study of testosterone gel replacement therapy and ambulatory blood pressure outcomes in men with hypogonadism.
    Weber MA; Aslam S; Efros MD; Chan A; Khan N; Li X; Dubcenco E; Miller MG
    Andrology; 2024 Oct; ():. PubMed ID: 39385523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.
    Gittelman M; Jaffe JS; Kaminetsky JC
    J Sex Med; 2019 Nov; 16(11):1741-1748. PubMed ID: 31551193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men.
    White WB; Dobs A; Carson C; DelConte A; Khera M; Miner M; Shahid M; Kim K; Chidambaram N
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):630-637. PubMed ID: 34191621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.
    Neutel J; Kereiakes DJ; Stoakes KA; Maa JF; Shojaee A; Waverczak WF
    Drugs Aging; 2011 Jun; 28(6):477-90. PubMed ID: 21639407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men.
    Swerdloff RS; Wang C; White WB; Kaminetsky J; Gittelman MC; Longstreth JA; Dudley RE; Danoff TM
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2515-31. PubMed ID: 32382745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men.
    White WB; Bernstein JS; Rittmaster R; Dhingra O
    J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1420-1430. PubMed ID: 34114726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.
    Cunningham G; Belkoff L; Brock G; Efros M; Gittelman M; Carrara D; Neijber A; Ando M; Mitchel J
    Endocr Pract; 2017 May; 23(5):557-565. PubMed ID: 28225313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy.
    Akkad AA; Halligan AW; Abrams K; al-Azzawi F
    Obstet Gynecol; 1997 Jan; 89(1):97-103. PubMed ID: 8990447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Safety of Testosterone-Replacement Therapy.
    Lincoff AM; Bhasin S; Flevaris P; Mitchell LM; Basaria S; Boden WE; Cunningham GR; Granger CB; Khera M; Thompson IM; Wang Q; Wolski K; Davey D; Kalahasti V; Khan N; Miller MG; Snabes MC; Chan A; Dubcenco E; Li X; Yi T; Huang B; Pencina KM; Travison TG; Nissen SE;
    N Engl J Med; 2023 Jul; 389(2):107-117. PubMed ID: 37326322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
    Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ; Neutel J
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of testosterone treatment, with and without exercise training, on ambulatory blood pressure in middle-aged and older men.
    Chasland LC; Green DJ; Schlaich MP; Maiorana AJ; Cooke BR; Cox KL; Naylor LH; Yeap BB
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):176-186. PubMed ID: 33580564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies.
    Belkoff L; Brock G; Carrara D; Neijber A; Ando M; Mitchel J
    Andrologia; 2018 Feb; 50(1):. PubMed ID: 28295450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Ravenell J; Shimbo D; Booth JN; Sarpong DF; Agyemang C; Beatty Moody DL; Abdalla M; Spruill TM; Shallcross AJ; Bress AP; Muntner P; Ogedegbe G
    Circulation; 2017 Jun; 135(25):2470-2480. PubMed ID: 28428231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.